
Lornova P 8mg/325mg Tablet
Marketer
Gnova Biotech
Salt Composition
Lornoxicam (8mg) + Paracetamol (325mg)
Overview Lornova P 8mg/325mg Tablet
Lornov P 8mg/325mg tablets offer pain relief and inflammation reduction. This medication treats conditions such as rheumatoid arthritis, ankylosing spondylitis, and osteoarthritis, along with muscle aches, back pain, dental pain, and ear, nose, and throat discomfort. Optimal absorption occurs on an empty stomach. Dosage is tailored to individual needs and response, always as directed by a physician. Never exceed the prescribed dosage or duration. Common side effects include nausea, vomiting, dyspepsia, abdominal pain, and diarrhea. Report any persistent or worsening side effects to your doctor, who can advise on mitigating strategies. Prior to use, inform your doctor of any history of gastric ulcers or bleeding, hypertension, or existing cardiovascular, renal, or hepatic issues. Disclose all other medications currently being taken, as interactions may occur. Pregnant or lactating individuals should seek medical consultation before commencing treatment. Alcohol consumption should be avoided due to the risk of increased drowsiness.
Uses of Lornova P 8mg/325mg Tablet
Analgesia
Major Benefits of Lornova P 8mg/325mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to the advised dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Lornova P 8mg/325mg tablets on an empty stomach.
Common Side effects of Lornova P 8mg/325mg Tablet:
- Nausea
- Vomiting
- Indigestion
- Stomach pain
- Diarrhea
How to use Lornova P 8mg/325mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Lornova P 8mg/325mg Tablet whole; avoid crushing, chewing, or breaking it. Administer on an empty stomach.
How Lornova P 8mg/325mg Tablet works:
Each Lornova P 8mg/325mg tablet combines lornoxicam and paracetamol to alleviate pain. This analgesic action stems from the inhibition of pain-inducing and inflammation-causing chemical mediators, thereby reducing swelling and redness.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol concurrently with Lornova P 8mg/325mg tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Data on Lornova P 8mg/325mg Tablet use in pregnancy is absent. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on the use of Lornova P 8mg/325mg tablets while breastfeeding is lacking. Seek medical advice from your physician.
DrivingCONSULT YOUR DOCTOR
The effect of Lornova P 8mg/325mg Tablet on driving ability is unknown. Refrain from driving if you develop symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Lornova P 8mg/325mg tablets can be administered safely to individuals with impaired renal function. No alteration in the dosage of Lornova P 8mg/325mg tablets is necessary.
LiverCONSULT YOUR DOCTOR
Data regarding the use of Lornova P 8mg/325mg Tablet in individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Lornova P 8mg/325mg Tablet :
Should you forget a Lornova P 8mg/325mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Lornova P 8mg/325mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Treatment | Pain Relievers |
